Screening device precisely identifies amblyopia in NIH-funded study
The device detected all six cases of amblyopia and/or strabismus in children aged two to six years.
Ophthalmic Devices
Latest in
Ophthalmic Devices
AXIM to acquire Advanced Tear Diagnostics’ DED testing technology
Through the deal, AXIM will obtain two US FDA-approved ophthalmic diagnostic lab tests to detect biomarkers for dry eye disease.
J&J Vision launches new system for cataract surgery
Leveraging WHITESTAR technology, along with elliptical tip movement, the VERITAS Vision System allows smoother cutting.
Flinders University develops genetic test for glaucoma
The latest test is carried out with a blood or saliva sample to potentially detect the disease prior to irreversible…
iSTAR Medical gets FDA nod to initiate trial of MINIject for glaucoma
Intended for treating primary open-angle glaucoma, MINIject can potentially lower intraocular pressure.
FDA grants priority review to BLA for Roche’s port delivery system
PDS is a permanent, refillable eye implant that can deliver continuous doses of ranibizumab for up to six months.
Australian TGA approves Glaukos’ PRESERFLO microshunt
PRESERFLO MicroShunt is designed to allow draining of eye fluid and lowering of IOP in primary open-angle glaucoma patients.
FDA approves J&J Vision’s therapeutic contact lenses for myopia
Johnson & Johnson Vision’s overnight therapeutic lenses receive FDA approval for myopia.